Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

55
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
55
Drug Nomenclature01:17

Drug Nomenclature

2.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.6K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

87
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
87
Drug Regulation01:25

Drug Regulation

2.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.2K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

57
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
57
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

44
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
44

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same author

A Qualitative Study to Explore the Influence of Condition Prioritisation in People With Coexisting Diabetes and Hypertension on Medication Adherence.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Community Health Workers' and Pharmacists' Perspectives of a CHW-Pharmacist Collaboration Model to Support Medication Adherence.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Interprofessional Collaboration Between Community Health Workers and Pharmacists.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Barriers and Enablers to Optimal Antimicrobial Use in Respiratory Tract Infections.

Antibiotics (Basel, Switzerland)·2025
Same author

Clinical Outcome of Redo-Surgery for Recurrent Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis Combined with a Case Series.

World neurosurgery·2025

Related Experiment Video

Updated: Nov 3, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K

Developing and user testing new pharmacy label formats-A study to inform labelling standards.

Vivien Tong1, Parisa Aslani1, David K Raynor2

  • 1The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|June 2, 2021
PubMed
Summary

Patient input improved prescription label design, enhancing safe medicine use. Clearer labels with active ingredients and dosing information help consumers understand and follow medication instructions effectively.

Keywords:
health communicationlabellinglabelsmedicine information

More Related Videos

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.9K
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

424

Related Experiment Videos

Last Updated: Nov 3, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.9K
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

424

Area of Science:

  • Health Sciences
  • Patient Safety
  • Human-Computer Interaction

Background:

  • Prescription medicine labels are crucial for safe and appropriate medication use.
  • Effective label design is essential for patient understanding and adherence.

Purpose of the Study:

  • To develop and user-test patient-centered prescription label formats.
  • To improve the clarity and usability of dispensed prescription medicine labels.

Main Methods:

  • Developed 12 prescription label formats for fictitious medicines.
  • Conducted two rounds of user testing with consumers (40 in Round 1, 20 in Round 2).
  • Assessed participants' ability to find information, understand dosage, and plan a dosing schedule.

Main Results:

  • All label formats allowed participants to understand dosage.
  • 14/19 labels met industry standards for performance, excluding active ingredient and dosing schedule.
  • Clear sign-posting of active ingredients improved identification, and dosing intervals/frequency aided schedule planning.

Conclusions:

  • Effective prescription label formatting and active ingredient sign-posting enhance communication.
  • Patient and public involvement is critical for developing readable and understandable medicine labels.
  • Improved label design can potentially support safer medication use.